Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients

Love, 1991, A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups, Medicine, 70, 360, 10.1097/00005792-199111000-00002

Betteridge, 2016, Myositis-specific autoantibodies: an important tool to support diagnosis of myositis, J. Int. Med., 280, 8, 10.1111/joim.12451

Muro, 2016, Cutaneous manifestations in dermatomyositis: key clinical and serological features-a comprehensive review, Clin. Rev. Allergy Immunol., 51, 293, 10.1007/s12016-015-8496-5

Gunawardena, 2017, The clinical features of myositis-associated autoantibodies: a review, Clin. Rev. Allergy Immunol., 52, 45, 10.1007/s12016-015-8513-8

McHugh, 2018, Autoantibodies in myositis, Nat. Rev. Rheumatol., 14, 290, 10.1038/nrrheum.2018.56

Mariampillai, 2018, Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies, JAMA Neurol., 75, 1528, 10.1001/jamaneurol.2018.2598

Svensson, 2017, Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study, Rheumatology, 56, 802, 10.1093/rheumatology/kew503

Bohan, 1975, Polymyositis and dermatomyositis (first of two parts), N. Engl. J. Med., 292, 344, 10.1056/NEJM197502132920706

Bohan, 1975, Polymyositis and dermatomyositis (second of two parts), N. Engl. J. Med., 292, 403, 10.1056/NEJM197502202920807

Lilleker, 2018, The EuroMyositis registry: an international collaborative tool to facilitate myositis research, Ann. Rheum. Dis., 77, 30, 10.1136/annrheumdis-2017-211868

Betteridge, 2007, Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia, Rheumatology, 46, 1005, 10.1093/rheumatology/kem045

Tansley, 2017, Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort, J. Autoimmun., 84, 55, 10.1016/j.jaut.2017.06.007

Tansley, 2014, Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study, Arthritis Res. Ther., 16, R138, 10.1186/ar4600

Tansley, 2014, Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset, Rheumatology, 53, 2204, 10.1093/rheumatology/keu259

R Development Core Team, 2015

Calcagno, 2010, Glmulti: an R package for easy automated model selection with (generalized) linear models, J. Stat. Softw., 34, 1, 10.18637/jss.v034.i12

Chen, 2015, Distinct profiles of myositis-specific autoantibodies in Chinese and Japanese patients with polymyositis/dermatomyositis, Clin. Rheumatol., 34, 1627, 10.1007/s10067-015-2935-9

Rider, 2013, The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies, Medicine, 92, 223, 10.1097/MD.0b013e31829d08f9

O'Hanlon, 2006, Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies, Medicine, 85, 111, 10.1097/01.md.0000217525.82287.eb

Cavazzana, 2016, Testing for myositis specific autoantibodies: comparison between line blot and immunoprecipitation assays in 57 myositis sera, J. Immunol. Meth., 433, 1, 10.1016/j.jim.2016.02.017

Hamaguchi, 2013, Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome, PLoS One, 8, 10.1371/journal.pone.0060442

Tampoia, 2016, A new immunodot assay for multiplex detection of autoantibodies in a cohort of Italian patients with idiopathic inflammatory myopathies, J. Clin. Lab. Anal., 30, 859, 10.1002/jcla.21948

Fiorentino, 2015, Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1gamma antibodies in adults with dermatomyositis, J. Am. Acad. Dermatol., 72, 449, 10.1016/j.jaad.2014.12.009

La Corte, 2006, In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease, Autoimmunity, 39, 249, 10.1080/08916930600623791

Marie, 2011, Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients, Arthritis Rheum., 63, 3439, 10.1002/art.30513

Fiorentino, 2011, The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study, J. Am. Acad. Dermatol., 65, 25, 10.1016/j.jaad.2010.09.016

Rogers, 2017, Cutaneous and systemic findings associated with nuclear matrix protein 2 antibodies in adult dermatomyositis patients, Arthritis Care Res., 69, 1909, 10.1002/acr.23210

Aggarwal, 2014, Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients, Ann. Rheum. Dis., 73, 227, 10.1136/annrheumdis-2012-201800

Klein, 2014, Arthritis in idiopathic inflammatory myopathy: clinical features and autoantibody associations, J. Rheumatol., 41, 1133, 10.3899/jrheum.131223

Qiang, 2017, Risk of malignancy in dermatomyositis and polymyositis, J. Cutan. Med. Surg., 21, 131, 10.1177/1203475416665601

Trallero-Araguas, 2012, Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis, Arthritis Rheum., 64, 523, 10.1002/art.33379

Fiorentino, 2013, Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1gamma, Arthritis Rheum., 65, 2954, 10.1002/art.38093

Petri, 2013, Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara, Arthritis Res. Ther., 15, R48, 10.1186/ar4207

Hengstman, 2006, Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen, Ann. Rheum. Dis., 65, 242, 10.1136/ard.2005.040717

Ichimura, 2012, Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy, Ann. Rheum. Dis., 71, 710, 10.1136/annrheumdis-2011-200697

Troyanov, 2014, Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features, Medicine, 93, 318, 10.1097/MD.0000000000000222

Yamasaki, 2016, Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52, Mod. Rheumatol., 26, 403, 10.3109/14397595.2015.1091155

Lundberg, 2005, Cardiac involvement in autoimmune myositis and mixed connective tissue disease, Lupus, 14, 708, 10.1191/0961203305lu2205oa

Hengstman, 2006, Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy, Ann. Rheum. Dis., 65, 1635, 10.1136/ard.2006.052191

Kao, 2004, Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy, Arthritis Rheum., 50, 209, 10.1002/art.11484

Marie, 1998, Pulmonary involvement in polymyositis and in dermatomyositis, J. Rheumatol., 25, 1336

Kang, 2005, Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis, Rheumatology, 44, 1282, 10.1093/rheumatology/keh723

Fathi, 2005, Interstitial lung disease in polymyositis and dermatomyositis, Curr. Opin. Rheumatol., 17, 701, 10.1097/01.bor.0000179949.65895.53

Lega, 2014, The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome, Autoimmun. Rev., 13, 883, 10.1016/j.autrev.2014.03.004

Chen, 2013, Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis, Arthritis Care Res., 65, 1316, 10.1002/acr.21985

Kobayashi, 2011, Anti-melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis, J. Pediatr., 158, 675, 10.1016/j.jpeds.2010.11.033

Narang, 2015, Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease, Arthritis Care Res., 67, 667, 10.1002/acr.22498

Cavazzana, 2008, Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases, Lupus, 17, 727, 10.1177/0961203308089442

Lundberg, 1992, Clinical manifestations and anti-(U1)snRNP antibodies: a prospective study of 29 anti-RNP antibody positive patients, Br. J. Rheumatol., 31, 811, 10.1093/rheumatology/31.12.811

Rigolet, 2012, Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease, Medicine, 91, 95, 10.1097/MD.0b013e31824d9cec

Coppo, 2002, Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: a subset of myositis associated with a favourable outcome, Rheumatology, 41, 1040, 10.1093/rheumatology/41.9.1040

Lundberg, 2017, 2017 european league against rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups, Arthritis Rheumatol., 69, 2271, 10.1002/art.40320